FS102

Bristol-Myers Squibb · Phase 1 active Small molecule

At a glance

Generic name	FS102
Also known as	Fcab, Fc region of full immunoglobulin G, subclass 1 [IgG1]
Sponsor	Bristol-Myers Squibb
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

FS102 CI brief — competitive landscape report
FS102 updates RSS · CI watch RSS
Bristol-Myers Squibb portfolio CI